Old Web
English
Sign In
Acemap
>
authorDetail
>
Alessio Perrotti
Alessio Perrotti
Immunology
Medicine
Oncology
Chronic lymphocytic leukemia
Exon
3
Papers
27
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Genomic Aberrations Dramatically Improve The Strong Prognostic Impact Of IGHV Mutational Status In Chronic Lymphocytic Leukemia (CLL)
2013
Blood
Giovanni Del Poeta
Dario Ragusa
Francesco Buccisano
Michele Dal Bo
Luca Maurillo
Antonella Zucchetto
Maria Ilaria Del Principe
Pasquale Niscola
Davide Rossi
Alessio Perrotti
Adriano Venditti
Paolo De Fabritiis
Valter Gattei
Gianluca Gaidano
Sergio Amadori
Show All
Source
Cite
Save
Citations (1)
A Phase II Trial of FM (Oral Fludarabine and Mitoxantrone) Chemotherapy Followed by Yttrium 90 (90Y) Ibritumomab Tiuxetan (Zevalin®) for Previously Untreated Follicular Lymphoma (FL) Patients.
2006
Blood
Pier Luigi Zinzani
Alessandro Pulsoni
Manuela Balocco
Monica Tani
Stefano Fanti
Alessio Perrotti
Paolo Castellucci
Francesco Zaja
Alberto Fabbri
Alfonso Zaccaria
Maria-Teresa Voso
Pierpaolo Fattori
Luciano Guardigni
Patrizia Gentilini
Maria Giuseppina Cabras
Amalia De Renzo
Luigi Rigacci
Show All
Source
Cite
Save
Citations (0)
Phase III Comparative Trial Uisng CHOP vs CIOP in the Treatment of Advanced Intermediate-Grade Non-Hodgkin's Lymphoma
1995
Leukemia & Lymphoma
Pier Luigi Zinzani
M.F. Martelli
Sergio Storti
Maurizio Musso
Maria Cantonetti
Giuseppe Leone
A. Cajozzo
Giuseppe Papa
Emilio Iannitto
Alessio Perrotti
Show All
Source
Cite
Save
Citations (26)
1